From Wikipedia, the free encyclopedia
Chemical compound
Doravirine
|
|
Trade names
| Pifeltro
|
---|
Other names
| MK-1439
|
---|
AHFS
/
Drugs.com
| Monograph
|
---|
MedlinePlus
| a618048
|
---|
License data
|
|
---|
Routes of
administration
| By mouth
[1]
[2]
|
---|
ATC code
| |
---|
|
Legal status
|
|
---|
|
3-Chloro-5-({1-[(4-methyl-5-oxo-4,5-dihydro-1
H
-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)-1,2-dihydro-3-pyridinyl}oxy)benzonitrile
|
CAS Number
| |
---|
PubChem
CID
| |
---|
DrugBank
| |
---|
ChemSpider
| |
---|
UNII
| |
---|
KEGG
| |
---|
ChEMBL
| |
---|
PDB ligand
| |
---|
CompTox Dashboard
(
EPA
)
| |
---|
ECHA InfoCard
| 100.234.454
|
---|
|
Formula
| C
17
H
11
Cl
F
3
N
5
O
3
|
---|
Molar mass
| 425.75
g·mol
?1
|
---|
3D model (
JSmol
)
| |
---|
Cn1c(n[nH]c1=O)Cn2ccc(c(c2=O)Oc3cc(cc(c3)Cl)C#N)C(F)(F)F
|
InChI=1S/C17H11ClF3N5O3/c1-25-13(23-24-16(25)28)8-26-3-2-12(17(19,20)21)14(15(26)27)29-11-5-9(7-22)4-10(18)6-11/h2-6H,8H2,1H3,(H,24,28)
Key:ZIAOVIPSKUPPQW-UHFFFAOYSA-N
|
Doravirine
, sold under the brand name
Pifeltro
, is a
non-nucleoside reverse transcriptase inhibitor
medication developed by
Merck & Co.
for use in the treatment of
HIV/AIDS
.
Doravirine was approved for medical use in the United States in August 2018.
[7]
Doravirine is available in
fixed-dose combinations
with other HIV drugs such as
doravirine/lamivudine/tenofovir
(sold under the brand name Delstrigo).
[8]
References
[
edit
]